# FDA 483 - Ravi K. Moparty, MD - December 03, 2021

Source: https://www.globalkeysolutions.net/records/483/ravi-k-moparty-md/b7a97939-4092-4fe3-90e8-e01702942413

> FDA 483 for Ravi K. Moparty, MD on December 03, 2021. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Ravi K. Moparty, MD
- Inspection Date: 2021-12-03
- Product Type: other
- Office Name: Division of Human and Animal Food Operations - West III
- Summary: An FDA inspection of Ravi K. Moparty, MD in Houston, TX, revealed that a clinical investigation was not conducted in accordance with the signed statement of investigator. Specifically, multiple subjects did not have screening and/or study-related procedures performed per the protocol, including issues with randomization timing, post-dose sample collection, and required screening tests. Additionally, informed consent documentation was found to be signed by staff eight weeks after the subject.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/zerita-white/82b19f0c-bd17-4a44-8523-8986f38851a8)

Company: https://www.globalkeysolutions.net/companies/ravi-k-moparty-md/894432ef-ec3e-458a-a94e-6ed5d79656ee

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-iii/2cda09a5-06c4-433f-9df0-0d7903a6efab